Published: 2023-11-12

Original Research Article

Run-up to participation in ATACH II in Japan

K Toyoda, S Sato, M Koga, H Yamamoto, J Nakagawara, E Furui, Y Shiokawa, Y Hasegawa, S Okuda, N Sakai, K Kimura, Y Okada, S Yoshimura, H Hoshino, Y Uesaka, T Nakashima, Y Itoh, T Ueda, T Nishi, J Gotoh, K Nagatsuka, S Arihiro, T Yamaguchi, K Minematsu
PDF https://doi.org/10.5281/zenodo.10349303

Expansion of recruitment time window in antihypertensive treatment of acute cerebral hemorrhage (ATACH) II trial

AI Qureshi, YY Palesch, ATACH II Investigators
PDF https://doi.org/10.5281/zenodo.10349388

The importance of an independent oversight committee to preserve treatment fidelity, ensure protocol compliance, and adjudicate safety endpoints in the ATACH II trial

NA McBee, DF Hanley, CS Kase, K Lane, JR Carhuapoma
PDF https://doi.org/10.5281/zenodo.10349427

Recruitment and retention monitoring: facilitating the mission of the National Institute of Neurological Disorders and Stroke (NINDS)

J Roberts, S Waddy, P Kaufmann
PDF https://doi.org/10.5281/zenodo.10349461

SCORE-IT: the Spot Sign score in restricting ICH growth─an Atach-II ancillary study

JN Goldstein, HB Brouwers, JM Romero, K McNamara, K Schwab, SM Greenberg, J Rosand
PDF https://doi.org/10.5281/zenodo.10349550

Mobile applications for handheld devices to screen and randomize acute stroke patients in clinical trials

AI Qureshi, B Connelly, EI Abbott, E Maland, J Kim, J Blake
PDF https://doi.org/10.5281/zenodo.10349584